An Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMR
Clinical trial NCT04711850 · TERMINATED
Trial details
- NCT number
- NCT04711850
- Sponsor
- Hansa Biopharma AB
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2021-01-20
- Primary completion
- 2023-03-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.